Many prognostic signatures, such as the 70-gene signature reported by van‘t Veer et al. [10] and the 76-gene signature reported by Wang et al. [11], have been developed for predicting clinical outcome of ER+ breast cancer patients accepting surgery only [12, 13]. This evidence concerns the gene ESR1 and breast carcinoma.